Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1994-4-18
pubmed:abstractText
Two nonfatal models of peritonitis differing by the duration and the severity of the disease were studied in rats by implantation of Escherichia coli and Bacteroides fragilis with or without increasing concentrations of Enterococcus faecalis. Results were evaluated at 3 or 6 days after inoculation. The highest enterococcal concentrations (10(9) cfu/mL) enhanced the severity of the infection, evident by increased emaciation, increased peritoneal counts of E. coli and B. fragilis, and increased frequency of E. coli and B. fragilis bacteremia compared with enterococcus-free animals. Six therapeutic regimens (low-dose amoxicillin + low-dose gentamicin, high-dose amoxicillin + high-dose gentamicin, pefloxacin, ornidazole, pefloxacin + ornidazole, imipenem + gentamicin) were tested. All treatments failed to eradicate E. faecalis except the combination pefloxacin + ornidazole, which achieved a significant reduction of local bacterial counts and suppressed bacteremia. Enterococcus played an important role in the mechanisms of bacterial synergy in experimental peritonitis. However, eradication of enterococcus did not seem possible by conventional antienterococcal therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0022-1899
pubmed:author
pubmed:issnType
Print
pubmed:volume
169
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
821-30
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8133097-Abscess, pubmed-meshheading:8133097-Amoxicillin, pubmed-meshheading:8133097-Animals, pubmed-meshheading:8133097-Anti-Bacterial Agents, pubmed-meshheading:8133097-Bacteremia, pubmed-meshheading:8133097-Bacteroides Infections, pubmed-meshheading:8133097-Bacteroides fragilis, pubmed-meshheading:8133097-Body Weight, pubmed-meshheading:8133097-Disease Models, Animal, pubmed-meshheading:8133097-Drug Synergism, pubmed-meshheading:8133097-Enterococcus faecalis, pubmed-meshheading:8133097-Escherichia coli, pubmed-meshheading:8133097-Escherichia coli Infections, pubmed-meshheading:8133097-Gentamicins, pubmed-meshheading:8133097-Gram-Positive Bacterial Infections, pubmed-meshheading:8133097-Imipenem, pubmed-meshheading:8133097-Male, pubmed-meshheading:8133097-Microbial Sensitivity Tests, pubmed-meshheading:8133097-Ornidazole, pubmed-meshheading:8133097-Pefloxacin, pubmed-meshheading:8133097-Peritoneum, pubmed-meshheading:8133097-Peritonitis, pubmed-meshheading:8133097-Rats, pubmed-meshheading:8133097-Rats, Sprague-Dawley, pubmed-meshheading:8133097-Specific Pathogen-Free Organisms
pubmed:year
1994
pubmed:articleTitle
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
pubmed:affiliation
INSERM U.13, Faculté Xavier Bichat, Hôpital Bichat, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't